1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,510 | 0,590 | 16:49 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.01. | ADVANCE ZINCTEK LIMITED: FDA Update | 1 | ASX | ||
| 12.12.25 | ADVANCE ZINCTEK LIMITED: Response to Television Broadcast Early This Week | - | ASX | ||
| 09.12.25 | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX | ||
| 08.12.25 | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
| 05.12.25 | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
| 28.11.25 | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
| ADVANCE ZINCTEK Aktie jetzt für 0€ handeln | |||||
| 17.11.25 | ADVANCE ZINCTEK LIMITED: FDA Inspection Update | - | ASX | ||
| 14.11.25 | ADVANCE ZINCTEK LIMITED: Results of Meeting | 1 | ASX | ||
| 13.11.25 | ADVANCE ZINCTEK LIMITED: Chair's Presentation to Shareholders | - | ASX | ||
| 17.10.25 | ADVANCE ZINCTEK LIMITED: Notice of Annual General Meeting/Proxy Form | 1 | ASX | ||
| 02.10.25 | ADVANCE ZINCTEK LIMITED: Improvement of 26.83% in First Quarter Revenue - FY26 | 2 | ASX | ||
| 26.09.25 | ADVANCE ZINCTEK LIMITED: Statement Regarding US Pharmaceutical Tariffs | - | ASX | ||
| 03.09.25 | ADVANCE ZINCTEK LIMITED: Response to Rumours Re CHOICE Sunscreen Test Findings | 1 | ASX | ||
| 29.08.25 | ADVANCE ZINCTEK LIMITED: Corporate Governance Statement | 2 | ASX | ||
| 29.08.25 | ADVANCE ZINCTEK LIMITED: Appendix 4G | 1 | ASX | ||
| 29.08.25 | ADVANCE ZINCTEK LIMITED: Annual Report to shareholders | 1 | ASX | ||
| 29.08.25 | ADVANCE ZINCTEK LIMITED: Appendix 4E | 1 | ASX |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 23,650 | +0,64 % | EQS-News: Formycon AG: Lotus Pharmaceutical wird Vermarktungspartner für Formycons Keytruda Biosimilar-Kandidaten FYB206 in weiten Teilen der Asien-Pazifik-Region | EQS-News: Formycon AG
/ Schlagwort(e): Vereinbarung
Lotus Pharmaceutical wird Vermarktungspartner für Formycons Keytruda Biosimilar-Kandidaten FYB206 in weiten Teilen der Asien-Pazifik-Region... ► Artikel lesen | |
| RIBER | 5,280 | -0,38 % | RIBER: 2025 performance driven by production systems and the rollout of ROSIE | 2025 performance driven by production systems and the rollout of ROSIE Revenues of €40.3 million in line with guidanceOrder book at December 31, 2025: €26.9 million (+24%) Bezons (France), February... ► Artikel lesen | |
| ONTO INNOVATION | 189,00 | +2,72 % | Beyond The Numbers: 8 Analysts Discuss Onto Innovation Stock | ||
| NANOFORM FINLAND | 0,757 | -2,32 % | Nanoform Finland Oyj: Inside information: Nanoform starts change negotiations as part of announced new midterm business targets for 2030 | Nanoform Finland Plc | Inside Information | January 07, 2026 at 08:05:00 EET
Helsinki, Finland - Nanoform Finland Plc ("Nanoform") starts change negotiations in accordance with the Act on Cooperation.... ► Artikel lesen | |
| KOPIN | 1,872 | -5,07 % | Kopin Corporation: Michael Murray, Kopin's CEO to Present at THEON International's Capital Markets Day (CMD) on November 6, 2025 | Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical... ► Artikel lesen | |
| ZENTEK | 0,530 | -3,64 % | Zentek Ltd.: Zentek Issues Shareholder Letter Outlining Strategic Reset and Focused Growth Plan | Guelph, Ontario--(Newsfile Corp. - January 29, 2026) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company") today announced that it has issued a letter to shareholders outlining a... ► Artikel lesen | |
| GAUZY | 0,780 | -1,39 % | Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Board Composition Requirements | TEL AVIV, Israel, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that it has received... ► Artikel lesen | |
| SOLESENCE | 1,450 | -0,68 % | Solésence, Inc.: Solésence Reports Third Quarter 2025 Financial Results | Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN)... ► Artikel lesen | |
| NANOVIRICIDES | 0,850 | +0,59 % | Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides | SHELTON, CONNECTICUT / ACCESS Newswire / February 10, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the... ► Artikel lesen | |
| GOMSPACE | 2,130 | +1,19 % | GomSpace Group AB: GomSpace announces 2026 market guidance with strong profitable growth | GomSpace, a leading provider of small satellite solutions, today provides an update on its 2026 financial guidance.
The company is pleased to announce comprehensive market guidance for 2026, reflecting... ► Artikel lesen | |
| OBDUCAT | 0,003 | +70,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.12.2025 | Das Instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 31.12.2025 und ex Kapitalmassnahme am 02.01.2026 The instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY... ► Artikel lesen | |
| ACACIA RESEARCH | 3,380 | -0,59 % | ACACIA RESEARCH CORP - 8-K, Current Report | ||
| NVE | 54,50 | -0,91 % | Dividendenbekanntmachungen (02.02.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUITY INC US00508Y1029 0,2 USD 0,1687 EUR ALLY FINANCIAL INC US02005N1000 0,3 USD 0,2531 EUR AMERISERV FINANCIAL INC US03074A1025 0... ► Artikel lesen | |
| LAMPETIA | 0,080 | 0,00 % | EQS-News: Lampetia AG: Halbjahresfinanzbericht auf neuer Webseite | EQS-News: Lampetia AG
/ Schlagwort(e): Halbjahresbericht
LAMPETIA AG: Halbjahresfinanzbericht auf neuer Webseite
30.09.2025 / 19:51 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| REGION GROUP | 1,326 | -7,60 % | Region Group 1H FY26 presentation: FFO growth and upgraded guidance on strong retail performance |
Das Unternehmen ADVANCE ZINCTEK LIMITED kann der Branche Nanotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell +0,99 % bei einem Aktienkurs von 0,510 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADVANCE ZINCTEK LIMITED finden Sie auf Wallstreet Online.